APA (7th ed.) Citation

AK, R., CA, S., FS, M., MA, W., S, C., Y, Y., . . . IK, D. (2023). Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023. MMWR. Morbidity and mortality weekly report, 72(9), 232. https://doi.org/10.15585/mmwr.mm7209a4

Chicago Style (17th ed.) Citation

AK, Rao, Schrodt CA, Minhaj FS, Waltenburg MA, Cash-Goldwasser S, Yu Y, Petersen BW, Hutson C, and Damon IK. "Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023." MMWR. Morbidity and Mortality Weekly Report 72, no. 9 (2023): 232. https://doi.org/10.15585/mmwr.mm7209a4.

MLA (9th ed.) Citation

AK, Rao, et al. "Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023." MMWR. Morbidity and Mortality Weekly Report, vol. 72, no. 9, 2023, p. 232, https://doi.org/10.15585/mmwr.mm7209a4.